Neurosteroid interactions with synaptic and extrasynaptic GABAA receptors: regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Neurosteroids are steroids synthesized within the brain with rapid effects on neuronal excitability. Allopregnanolone, allotetrahydrodeoxycorticosterone, and androstanediol are three widely explored prototype endogenous neurosteroids. They have very different targets and functions compared to conventional steroid hormones. Neuronal γ-aminobutyric acid (GABA) type A (GABAA) receptors are one of the prime molecular targets of neurosteroids. This review provides a critical appraisal of recent advances in the pharmacology of endogenous neurosteroids that interact with GABAA receptors in the brain. Neurosteroids possess distinct, characteristic effects on the membrane potential and current conductance of the neuron, mainly via potentiation of GABAA receptors at low concentrations and direct activation of receptor chloride channel at higher concentrations. The GABAA receptor mediates two types of inhibition, now characterized as synaptic (phasic) and extrasynaptic (tonic) inhibition. Synaptic release of GABA results in the activation of low-affinity γ2-containing synaptic receptors, while high-affinity δ-containing extrasynaptic receptors are persistently activated by the ambient GABA present in the extracellular fluid. Neurosteroids are potent positive allosteric modulators of synaptic and extrasynaptic GABAA receptors and therefore enhance both phasic and tonic inhibition. Tonic inhibition is specifically more sensitive to neurosteroids. The resulting tonic conductance generates a form of shunting inhibition that controls neuronal network excitability, seizure susceptibility, and behavior. The growing understanding of the mechanisms of neurosteroid regulation of the structure and function of the synaptic and extrasynaptic GABAA receptors provides many opportunities to create improved therapies for sleep, anxiety, stress, epilepsy, and other neuropsychiatric conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor
Majewska, M. D., Harrison, N. L., Schwartz, R. D., Barker, J. L., & Paul, S. M. (1986) · Science · doi:10.1126/science.2422758 · Cited by 2,225 · cited 1×
“A major advance occurred when 5α-reduced metabolites of progesterone and deoxycorticosterone were found to enhance GABA A receptor function (Majewska et al. 1986; Kulkarni and Reddy 1995).”
The K+/Cl− co-transporter KCC2 renders GABA hyperpolarizing during neuronal maturation
Rivera, C., Voipio, J., Payne, J. A., Ruusuvuori, E., Lahtinen, H., Lamsa, K., Pirvola, U., Saarma, M., & Kaila, K. (1999) · Nature · doi:10.1038/16697 · Cited by 2,152 · cited 2×
“As the brain matures, a negative shift in the chloride ion reversal potential induces the electrochemical gradient to allow for inward current flow when the GABA A receptor channel is opened (Rivera et al. 1999).”
Variations on an inhibitory theme: phasic and tonic activation of GABAA receptors
Farrant, M., & Nusser, Z. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1625 · Cited by 2,081 · cited 4×
“Phasic inhibition is attributed to the inhibitory postsynaptic current (IPSC) resultant from membrane receptor opening in response to rapid release of GABA across the synapse and binding GABAA receptors as a traditional neurotransmitter (Farrant and Nusser 2005).”
InfluentialNeurosteroids: endogenous regulators of the GABAA receptor
Belelli, D., & Lambert, J. J. (2005) · Nature reviews. Neuroscience · doi:10.1038/nrn1703 · Cited by 1,159 · cited 3×
“…GABAergic current at 10–500 nM concentrations and to autonomously, directly induce receptor channel opening at larger concentrations (>500 nM) (Belelli and Lambert 2005), neurosteroids appear to operate on a wider array of receptor isoforms and are thus less specific in binding as compared…”
Purdy, R. H., Morrow, A. L., Moore, P. H., & Paul, S. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.10.4553 · Cited by 951
Rupprecht, R., Papadopoulos, V., Rammes, G., Baghai, T. C., Fan, J., Akula, N., Groyer, G., Adams, D., & Schumacher, M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3295 · Cited by 930 · cited 1×
“Activation of TSPO by certain ligands facilitates increased neurosteroid production (Kita and Furukawa 2008; Rupprecht et al. 2009, 2010).”
Neurosteroids: biosynthesis and function of these novel neuromodulators
Compagnone, N. A., & Mellon, S. H. (2000) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1999.0188 · Cited by 820 · cited 1×
“Taken together, all of the necessary enzymes required for steroid synthesis are region specific, cell specific, and available within the neural tissue, both in neurons and glia (Compagnone and Mellon 2000; Porcu et al. 2009).”
Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites
Hosie, A. M., Wilkins, M. E., da Silva, H. M. A., & Smart, T. G. (2006) · Nature · doi:10.1038/nature05324 · Cited by 752 · cited 1×
“…act as positive modulators: one for allosteric enhancement of GABA and another for direct activation of the receptor, as well as an antagonistic transduction site for sulfated neurosteroids involving the M2 region of the α subunit (Akk et al. 2001; Lambert et al. 2003; Hosie et al. 2006, 2007).”
Neurosteroids and GABAA receptor function
Lambert, J. J., Belelli, D., Hill-Venning, C., & Peters, J. A. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)89058-6 · Cited by 746
Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes
Rudolph, U., & Knoflach, F. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3502 · Cited by 733 · cited 3×
“…, ∼15–20 % have the α 2 β 3 γ 2 combination, ∼10–15 % have the α 3 β x γ 2 combination, ∼ 5 % have the α 4 β x γ or α 4 β x δ combination, less than 5 % have the α 5 β 2 γ 2 combination, and, likewise, less than 5 % have the α 6 β 2/3 γ 2 combination (Mohler et al. 2002; Rudolph and Knoflach 2011).”
A new benzodiazepine pharmacology
Möhler, H., Fritschy, J. M., & Rudolph, U. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.1.2 · Cited by 716 · cited 2×
“…, ∼15–20 % have the α 2 β 3 γ 2 combination, ∼10–15 % have the α 3 β x γ 2 combination, ∼ 5 % have the α 4 β x γ or α 4 β x δ combination, less than 5 % have the α 5 β 2 γ 2 combination, and, likewise, less than 5 % have the α 6 β 2/3 γ 2 combination (Mohler et al. 2002; Rudolph and Knoflach 2011).”
GABAA receptor trafficking and its role in the dynamic modulation of neuronal inhibition
Jacob, T. C., Moss, S. J., & Jurd, R. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2370 · Cited by 695
Zhang, H., & Maloney, L. T. (2012) · Frontiers in Neuroscience · doi:10.3389/fnins.2012.00001 · Cited by 679
Shunting Inhibition Modulates Neuronal Gain during Synaptic Excitation
Mitchell, S. J., & Silver, R. A. (2003) · Neuron · doi:10.1016/s0896-6273(03)00200-9 · Cited by 602 · cited 1×
“Tonic current enables shunting inhibition to control gain of neuronal excitability (Mitchell and Silver 2003).”
GABAA receptor α4 subunit suppression prevents withdrawal properties of an endogenous steroid
Smith, S. S., Gong, Q. H., Hsu, F.-C., Markowitz, R. S., ffrench-Mullen, J. M. H., & Li, X. (1998) · Nature · doi:10.1038/31948 · Cited by 564 · cited 1×
“Induced neurosteroid withdrawal following chronic doses of progesterone or allopregnanolone in rodents has shown to increase the expression of α 4 subunit approximately 3-fold (Smith et al. 1998; Gangisetty and Reddy 2009, 2010).”
Extrasynaptic GABA A Receptors: Form, Pharmacology, and Function
Belelli, D., Harrison, N. L., Maguire, J., Macdonald, R. L., Walker, M. C., & Cope, D. W. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3340-09.2009 · Cited by 464 · cited 5×
“Levels of neurosteroid in plasma and brain have been estimated to be between 10 and 300 nM, owing to a variety of physiological and pathophysiological conditions (Belelli et al. 2009).”
InfluentialGABAAR Plasticity during Pregnancy: Relevance to Postpartum Depression
Maguire, J., & Mody, I. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.019 · Cited by 437
Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties
Rupprecht, R. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00064-1 · Cited by 427
Anesthetic Effect of Steroid Hormones.
Selye, H. (1941) · Experimental Biology and Medicine · doi:10.3181/00379727-46-11907 · Cited by 375
Which GABA A Receptor Subunits Are Necessary for Tonic Inhibition in the Hippocampus?
Glykys, J., Mann, E. O., & Mody, I. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4751-07.2008 · Cited by 370
Activation of GABAA Receptors: Views from Outside the Synaptic Cleft
Glykys, J., & Mody, I. (2007) · Neuron · doi:10.1016/j.neuron.2007.11.002 · Cited by 358 · cited 6×
“The prevalent perception is that surplus GABA spillover from vesicular synaptic release contributes to tonic current in neurons that contain extrasynaptic, δ-containing receptors like CGCs and DGGCs (Hamann et al. 2002; Wei et al. 2003; Glykys and Mody 2007).”
InfluentialTranslocator protein (18 kD) as target for anxiolytics without benzodiazepine-like side effects
Rupprecht, R., Rammes, G., Eser, D., Baghai, T. C., Schüle, C., Nothdurfter, C., Troxler, T., Gentsch, C., Kalkman, H. O., Chaperon, F., et al. (2009) · Science · doi:10.1126/science.1175055 · Cited by 328
Otis, T. S., De Koninck, Y., & Mody, I. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7698 · Cited by 257 · cited 1×
“DGGCs from TLE rats have increased synaptic efficacy, exemplified by increase in number of postsynaptic channels, but not channel conductance (Otis et al. 1994).”
Sarkar, J., Wakefield, S., MacKenzie, G., Moss, S. J., & Maguire, J. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.2560-11.2011 · Cited by 254
Peng, Z., Hauer, B., Mihalek, R. M., Homanics, G. E., Sieghart, W., Olsen, R. W., & Houser, C. R. (2002) · Journal of Comparative Neurology · doi:10.1002/cne.10210 · Cited by 247
Basic pharmacologic mechanisms involved in benzodiazepine tolerance and withdrawal
Bateson, A. (2002) · Current Pharmaceutical Design · doi:10.2174/1381612023396681 · Cited by 240
Regulation of GABAA Receptor Subunit Expression by Pharmacological Agents
Uusi-Oukari, M., & Korpi, E. R. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002063 · Cited by 213
Neurosteroid modulation of synaptic and extrasynaptic GABAA receptors
Herd, M. B., Belelli, D., & Lambert, J. J. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.03.007 · Cited by 206
Neurosteroids: Endogenous allosteric modulators of GABAA receptors
Lambert, J. J., Cooper, M. A., Simmons, R. D. J., Weir, C. J., & Belelli, D. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.08.009 · Cited by 180 · cited 2×
“However, at greater concentrations reaching 1 μM and above, neurosteroids are able to directly activate the gating of the chloride channel without GABA (Reddy and Rogawski 2002; Lambert et al. 2009).”
Neurosteroid Prolongs GABAAChannel Deactivation by Altering Kinetics of Desensitized States
Zhu, W. J., & Vicini, S. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-11-04022.1997 · Cited by 168 · cited 1×
“Endogenous neurosteroids modify neuronal GABA A current by increasing the channel opening duration, prolonging slow deactivation and delayed recovery from desensitization (Zhu and Vicini 1997; Wohlfarth et al. 2002).”
The role of neurosteroids in the pathophysiology and treatment of catamenial epilepsy
Reddy, D. S. (2009) · Epilepsy Research · doi:10.1016/j.eplepsyres.2009.02.017 · Cited by 167
Self-citationGABAA Receptors in Normal Development and Seizures: Friends or Foes?
Galanopoulou, A. (2008) · Current Neuropharmacology · doi:10.2174/157015908783769653 · Cited by 156
Ebert, B., Thompson, S. A., Saounatsou, K., McKernan, R., Krogsgaard-Larsen, P., & Wafford, K. A. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.6.1150 · Cited by 145
Akk, G., Bracamontes, J., & Steinbach, J. H. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.0673e.x · Cited by 137 · cited 5×
“It is also possible for sub-micromolar levels of neurosteroid to directly gate GABA A receptors at a slower, gradual rate due to accumulation within the plasma membrane (Shu et al. 2004; Akk et al. 2009).”
InfluentialKorneyev, A., Pan, B. S., Polo, A., Romeo, E., Guidotti, A., & Costa, E. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb13647.x · Cited by 132
Enhanced anticonvulsant activity of neuroactive steroids in a rat model of catamenial epilepsy
Reddy, D. S., & Rogawski, M. A. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.10200.x · Cited by 130 · cited 1×
“…GABA A receptor modulator drugs including neurosteroids and benzodiazepines and also due to other types of agents such as ethanol, which may act in part through GABA A receptors, and cocaine, which does not (Tsuda et al. 1997; Devaud et al. 1996; Reddy and Rogawski 2000a, 2001; Reddy et al. 2012).”
Self-citationMitochondrial protein import and the genesis of steroidogenic mitochondria
Midzak, A., Rone, M., Aghazadeh, Y., Culty, M., & Papadopoulos, V. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.12.007 · Cited by 89 · cited 2×
“Additionally, recent findings suggest that neurosteroids or biochemically similar compounds may have a role in controlling their own biosynthesis through negative feedback loops to interact with TSPO and inhibit cholesterol utilization during steroidogenesis (Midzak et al. 2011a).”
Gangisetty, O., & Reddy, D. S. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.07.037 · Cited by 84 · cited 2×
“Many studies report compensational changes of subunit expression due to genetic, functional, or pharmacological changes to the control of GABAergic inhibition (Peng et al. 2002; Liang et al. 2008; Gangisetty and Reddy 2010; Uusi-Oukari and Korpi 2010; Suryanarayanan et al. 2011; Kuver et al. 2012).”
Self-citationChen, Z.-W., Manion, B., Townsend, R. R., Reichert, D. E., Covey, D. F., Steinbach, J. H., Sieghart, W., Fuchs, K., & Evers, A. S. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.078410 · Cited by 72 · cited 1×
“A recent report identified a novel β 3 subunit transmembrane domain involved in neurosteroid binding (Chen et al. 2012).”
Midzak, A., Akula, N., Lecanu, L., & Papadopoulos, V. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.203216 · Cited by 69 · cited 2×
“Additionally, recent findings suggest that neurosteroids or biochemically similar compounds may have a role in controlling their own biosynthesis through negative feedback loops to interact with TSPO and inhibit cholesterol utilization during steroidogenesis (Midzak et al. 2011a).”
Tuveri, A., Paoletti, A. M., Orrù, M., Melis, G. B. B., Marotto, M. F., Zedda, P., Marrosu, F., Sogliano, C., Marra, C., Biggio, G., et al. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01555.x · Cited by 63 · cited 1×
“In women with perimenstrual catamenial epilepsy, overall THDOC levels and DHEAS/cortisol ratio are reduced, but the pregnane steroids progesterone, pregnenolone, and allopregnanolone are not different compared to control groups (Tuveri et al. 2008).”
Cited by
The GABAA Receptor as a Therapeutic Target for Neurodevelopmental Disorders
Braat, S., & Kooy, R. F. (2015) · Neuron · doi:10.1016/j.neuron.2015.03.042 · Cited by 294
An emerging circuit pharmacology of GABAA receptors
Engin, E., Benham, R. S., & Rudolph, U. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.04.003 · Cited by 225
Nimgampalle, M., Chakravarthy, H., Sharma, S., Shree, S., Bhat, A. R., Pradeepkiran, J. A., & Devanathan, V. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101994 · Cited by 207
GABAA receptors and plasticity of inhibitory neurotransmission in the central nervous system
Fritschy, J., & Panzanelli, P. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12534 · Cited by 198
“…cells, are considered to be crucial regulators of neuronal function and excitability under both physiological and pathological conditions, and represent promising novel targets for specific neurological and psychiatric indications [reviewed in Belelli & Lambert (2005) and Carver & Reddy (2013)].”
BackgroundThe GABAergic system as a therapeutic target for Alzheimer's disease
Calvo‐Flores Guzmán, B., Vinnakota, C., Govindpani, K., Waldvogel, H. J., Faull, R. L. M., & Kwakowsky, A. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14345 · Cited by 171
Metadata
- Authors
- Carver, C. M., & Reddy, D. S.
- Venue
- Psychopharmacology
- Published
- 2013-09-27
- Volume
- 230
- Issue
- 2
- Pages
- 151-188
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2055973066
- Cited by
- 248
- References
- 41
- FWCI
- 8.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.